A large and potentially disturbing number of leading academic figures serve on the board of directors of public healthcare companies, according to a new study published in BMJ. “These kind of industry relationships have not been front and center in most debates about conflict of interest (COI),” David Rothman, PhD, a medical historian at Columbia University, noted in…
Double Duty: Academic Leaders, Corporate Boards, And The Harvard Connection
September 29, 2015 by 3 Comments
Lancet Editors Raise More Questions About Prominent Harvard Stem Cell Researcher
April 11, 2014 by Leave a Comment
There’s more trouble for Piero Anversa, the prominent and controversial stem cell researcher. Today the Lancet issued an expression of concern about an influential, much-cited stem cell paper. As first reported by Retraction Watch, an investigation at Harvard Medical School and Brigham and Women’s Hospital has raised concerns about the integrity of data coming from Piero Anversa’s laboratory at the Brigham…
Circulation Retracts Paper By Stem Cell Pioneer And Its Own Editor
April 8, 2014 by Leave a Comment
Following an investigation by Harvard Medical School and Brigham and Women’s Hospital a 2012 paper published in Circulation has been retracted. The “institutional review… determined that the data are sufficiently compromised that a retraction is warranted.” The two senior authors of the paper are Piero Anversa, a pioneering researcher in cardiac stem cells, and Joseph Loscalzo, the editor-in-chief of Circulation and the…
Recent Comments